09/29/2025 | Press release | Distributed by Public on 09/29/2025 12:31
Cravath represented Artivion, Inc. in connection with $400 million of credit facilities obtained from Ares Management Credit funds. Artivion is a leader in the manufacturing, processing and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The transaction closed on September 12, 2025.
The Cravath team included partner Joseph D. Zavaglia and associates Kathryn Kennedy Bleday and Jamye Selby.